DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

PDL BioPharma (NASDAQ: PDLI)

9.71 -0.11 (-1.12%)

REAL-TIME: Last trade at

Extended Hours: $9.71 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PDLI $9.71 -1.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.88
Previous Close $9.82
Daily Range $9.67 - $9.88
52-Week Range $7.38 - $10.21
Market Cap $1.6B
P/E Ratio 5.99
Dividend (Yield) $0.60 (6.1%)
Ex-Dividend Date
Dividend Pay Date
09/03/14
09/12/14
Volume 1,736,726
Average Daily Volume 2,497,171
Current FY EPS $2.22

Sector

Healthcare

Industry

Drugs

PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website: http://www.pdl.com/

News & Commentary

3 Reasons Why Shorts Are Moving into Durata Therapeutics

Despite a recent FDA approval of Durata's new antibiotic Dalvance for acute bacterial skin and skin structure infections, shorts have steadily increased their position in the stock. Here's what you need to know.

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Operating Margin

Company News for August 20, 2014 - Corporate Summary

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2014 Results - Earnings Call Transcript

Sector Update: Health Care Stocks Inching Higher; PDL BioPharma Retreats From Session Highs After Q2

Sector Update: Health Care Stocks Inching Higher; PDL BioPharma Retreats From Session Highs After Q2 Profit Slips From Year-Ago Levels

Sector Update: Health Care

PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog

Morning Market Movers

Benzinga's Top #PreMarket Gainers

Earnings Reaction History: PDL BioPharma Inc, 100.0% Follow-Through Indicator, 18.3% Sensitive

What To Buy: Top 3 Buy-Rated Dividend Stocks: HCN, PDLI, EEP

See More PDLI News...

PDLI's Top Competitors

PDLI $9.71 (-1.12%)
Current stock: PDLI
AMGN $132.82 (0.22%)
Current stock: AMGN
CELG $91.62 (-0.04%)
Current stock: CELG
BIIB $339.97 (0.39%)
Current stock: BIIB